Search results
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 2 hours agoPfizer's Abrysvo is one of three new respiratory syncytial virus (RSV) vaccines approved to prevent...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 1 day agoWith sales of the Cambridge drugmaker’s Covid-19 vaccine declining as the pandemic becomes endemic,...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 5 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 23 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 23 hours ago(NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The company had said...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
US FDA approves Moderna’s RSV vaccine, its second marketed product
KFGO· 4 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 22 hours agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 4 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
BioNTech gets $145 million funding for African vaccine plants
Reuters via Yahoo News· 6 days agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...